Today we are thanking 40,000 of you for following us on LinkedIn! This milestone means a step forward on Asphalion’s goal of improving lives. Thanks to your support, we are able to share valuable insights, industry news, and important updates—ultimately reaching more people and making a bigger impact every day.
If you are not following us yet, check out our LinkedIn profile.
Let’s keep growing together!
Search News & Events
Share
In this People Talks, we hear from Patricia Mármol, who shares her rewarding journey at Asphalion.
Thalassemia refers to a heterogenous group of inherited anaemias that are collectively recognised as one of the most common hereditary diseases in the world. Thalassemia
Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts.
We will be happy to assist you!
